Wnt2 is overexpressed in many stages of the development of colorectal cancer [25], and Wnt5a is overexpressed in breast cancer, colorectal cancer, lung cancer, prostate cancer and melanoma [26, 27]. The gene discussed is WNT2; the disease is prostate carcinoma.